The effect of citrus flavonoids on the redox state of alimentary-induced fatty liver in rats

Both chronic venous insufficiency (CVI) and fatty liver may develop at the same time. Hesperidin and diosmin are used for the treatment CVI. There is no information, however, on the effect of these flavonoids in the redox state of fatty liver. In this study, male Wistar albino rats were fed a lipid-rich diet with or without 450 mg diosmin–50 mg hesperidin-containing drug (60 mg kg−1body weight/day, per os) for 9 days to determine the impact of treatment on antioxidant defence system of the fatty liver. We detected free SH-group concentration (SHC), hydrogen-donating ability (HDA), and natural scavenger capacity were decreased and hepatic malonaldehyde content and dien conjugate (DC) content in rats with fatty liver were increased compared to the control. After treatment in fatty liver, these parameters (except DC) significantly improved and approached the control value. Our results indicate that diosmin–hesperidin-containing drug may be a useful agent in improving the antioxidant defensive system in alimentary-induced fatty liver disease.

[1]  P. Smith.  Neutrophil Activation and Mediators of Inflammation in Chronic Venous Insufficiency , 1999, Journal of Vascular Research.

[2]  J. Féher,et al.  Oxidative stress in the liver and biliary tract diseases. , 1998, Scandinavian journal of gastroenterology. Supplement.

[3]  P. Villa,et al.  Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. , 1992, Toxicology.

[4]  J. Féher,et al.  Liver protecting and lipid lowering effects of Sempervivum tectorum extract in the rat , 1993 .

[5]  T. Hatano,et al.  Two new flavonoids and other constituents in licorice root: their relative astringency and radical scavenging effects. , 1988, Chemical & pharmaceutical bulletin.

[6]  K. Chopra,et al.  Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney , 2005, BMC pharmacology.

[7]  R. Yu,et al.  Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis , 2000, Archives of pharmacal research.

[8]  D. Lane,et al.  Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. , 2000, Current medicinal chemistry.

[9]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[10]  H. Tsukamoto.  Redox regulation of cytokine expression in Kupffer cells. , 2002, Antioxidants & redox signaling.

[11]  J. Manthey.  Biological Properties of Flavonoids Pertaining to Inflammation , 2000, Microcirculation.

[12]  C. Rice-Evans,et al.  Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.

[13]  C. Labrid.  Changes in blood pressure reactivity and 24-hour blood pressure profile occurring at puberty. , 1994 .

[14]  A. Zarzuelo,et al.  Anti-Inflammatory Activity of Diosmin and Hesperidin in Rat Colitis Induced by TNBS , 1999, Planta medica.

[15]  L. Pyles,et al.  Spectrophotometric Measurement of Plasma 2-Thiobarbituric Acid-Reactive Substances in the Presence of Hemoglobin and Bilirubin Interference , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[16]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[17]  P. Portincasa,et al.  Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management. , 2005, Clinical biochemistry.

[18]  G. Gores,et al.  Mechanisms of hepatotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  T. Osawa,et al.  Protective effects of lemon flavonoids on oxidative stress in diabetic rats , 1998, Lipids.

[20]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[21]  J. Féher,et al.  Free Radicals and the Liver , 1992, Springer Berlin Heidelberg.

[22]  P. Moreau.  Lipids , 2007 .

[23]  B. Lal,et al.  Does severe venous insufficiency have a different etiology in the morbidly obese? Is it venous? , 2003, Journal of vascular surgery.

[24]  R. Rodrigo,et al.  Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. , 2004, Free radical biology & medicine.

[25]  J. Féher,et al.  Antioxidant defense in erythrocytes and plasma of patients with active and quiescent Crohn disease and ulcerative colitis: a chemiluminescent study. , 1999, Clinical chemistry.

[26]  Myung‐Sook Choi,et al.  Hypocholesterolemic effect of hesperetin mediated by inhibition of 3-hydroxy-3-methylgultaryl coenzyme a reductase and acyl coenzyme a: Cholesterol acyltransferase in rats fed high-cholesterol diet , 1999 .

[27]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[28]  H. Cortez‐Pinto,et al.  Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. , 2004, Best practice & research. Clinical gastroenterology.

[29]  Mi-Kyung Lee,et al.  Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[30]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[31]  J. Fillastre,et al.  Effet protecteur des flavonoïdes contre la toxicité de la vinblastine, du cyclophosphamide et du paracétamol par inhibition de la peroxydation lipidique et augmentation du glutathion hépatique , 2004 .

[32]  N Guthrie,et al.  Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. , 1996, Nutrition and cancer.

[33]  S. Jovanovic,et al.  Antioxidants in Nutrition , 2000, Annals of the New York Academy of Sciences.

[34]  M. Oyaizu.  Studies on products of browning reaction--antioxidative activities of products of browning reaction prepared from glucosamine , 1986 .

[35]  G. Jantet.  Chronic Venous Insufficiency: Worldwide Results of the RELIEF Study , 2002, Angiology.

[36]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[37]  K. Grohmann,et al.  Biological properties of citrus flavonoids pertaining to cancer and inflammation. , 2001, Current medicinal chemistry.